Back
Top 0.1%
15.0%
Top 9%
15.0%
Top 46%
15.0%
Top 0.3%
6.6%
Top 1%
6.1%
Top 2%
5.2%
Top 4%
4.0%
Top 0.6%
4.0%
Top 73%
2.9%
Top 11%
2.0%
Top 0.9%
2.0%
Top 0.6%
1.4%
Top 13%
1.2%
Top 16%
1.0%
Top 44%
1.0%
Top 5%
0.7%
Top 3%
0.7%
Top 6%
0.7%
Top 13%
0.7%
Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): Consensus on Obesity and Cardiometabolic Comorbidities in Inflammatory Bowel Disease using Evidence Synthesis and the RAND/UCLA Appropriateness Method
2025-12-22
gastroenterology
Title + abstract only
View on medRxiv
Show abstract
IntroductionObesity and related cardiometabolic comorbidities, including hypertension, dyslipidemia, diabetes, metabolic dysfunction-associated steatotic liver disease (MASLD), and atherosclerotic cardiovascular disease (ASCVD), are increasingly prevalent among individuals with inflammatory bowel disease (IBD). These conditions influence disease activity, therapeutic response, surgical outcomes, and overall quality of life, yet evidence remains fragmented. The Modulate Obesity and relateD metabo...
Predicted journal destinations
1
American Journal of Gastroenterology
15 training papers
2
BMJ Open
553 training papers
3
PLOS ONE
1737 training papers
4
Gut
17 training papers
5
Vaccines
131 training papers
6
Frontiers in Medicine
99 training papers
7
Journal of Clinical Medicine
77 training papers
8
Gut Microbes
15 training papers
9
Scientific Reports
701 training papers
10
BMC Medicine
155 training papers
11
Frontiers in Pharmacology
27 training papers
12
Aging
18 training papers
13
PLOS Medicine
95 training papers
14
Cureus
64 training papers
15
eLife
262 training papers
16
Nutrients
43 training papers
17
Biomedicines
21 training papers
18
BMC Cancer
21 training papers
19
Frontiers in Immunology
140 training papers